| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |